Gene symbol: Drd2

Organism: Rattus norvegicus

Summary: Enables several functions, including dopamine binding activity; dopamine neurotransmitter receptor activity, coupled via Gi/Go; and ionotropic glutamate receptor binding activity. Involved in several processes, including modulation of chemical synaptic transmission; nervous system development; and regulation of protein modification process. Located in several cellular components, including cytoplasmic vesicle; lateral plasma membrane; and perikaryon. Is active in GABA-ergic synapse and glutamatergic synapse. Is integral component of postsynaptic membrane and integral component of presynaptic membrane. Used to study Parkinsonism; cocaine dependence; and ovarian hyperstimulation syndrome. Biomarker of several diseases, including Gilles de la Tourette syndrome; drug psychosis; hyperprolactinemia; opiate dependence (multiple); and toxic encephalopathy. Human ortholog(s) of this gene implicated in several diseases, including end stage renal disease; mental depression; migraine with aura; obesity; and type 2 diabetes mellitus. Orthologous to human DRD2 (dopamine receptor D2). [provided by Alliance of Genome Resources, Apr 2022]

NCBI gene ID: 24318 EnsemblRapid:ENSRNOG00000008428 AllianceGenome:RGD:2520


GO Annotation


Category Term ID Term description
Process GO:0000902 Cell morphogenesis
Process GO:0000904 Cell morphogenesis involved in differentiation
Process GO:0001504 Neurotransmitter uptake
Process GO:0001505 Regulation of neurotransmitter levels
Process GO:0001654 Eye development
Process GO:0001659 Temperature homeostasis
Process GO:0001666 Response to hypoxia
Process GO:0001763 Morphogenesis of a branching structure
Process GO:0001764 Neuron migration
Process GO:0001817 Regulation of cytokine production
Process GO:0001819 Positive regulation of cytokine production
Process GO:0001932 Regulation of protein phosphorylation
Process GO:0001933 Negative regulation of protein phosphorylation
Process GO:0001934 Positive regulation of protein phosphorylation
Process GO:0001963 Synaptic transmission, dopaminergic
Process GO:0001964 Startle response
Process GO:0001975 Response to amphetamine
Process GO:0001976 Nervous system process involved in regulation of systemic arterial blood pressure
Process GO:0002027 Regulation of heart rate
Process GO:0002028 Regulation of sodium ion transport
Process GO:0002029 Desensitization of G protein-coupled receptor signaling pathway
Process GO:0002031 G protein-coupled receptor internalization
Process GO:0002052 Positive regulation of neuroblast proliferation
Process GO:0002090 Regulation of receptor internalization
Process GO:0002092 Positive regulation of receptor internalization
Process GO:0002682 Regulation of immune system process
Process GO:0002683 Negative regulation of immune system process
Process GO:0002791 Regulation of peptide secretion
Process GO:0002792 Negative regulation of peptide secretion
Process GO:0002793 Positive regulation of peptide secretion
Process GO:0002831 Regulation of response to biotic stimulus
Process GO:0002832 Negative regulation of response to biotic stimulus
Process GO:0003008 System process
Process GO:0003012 Muscle system process
Process GO:0003013 Circulatory system process
Process GO:0003014 Renal system process
Process GO:0003073 Regulation of systemic arterial blood pressure
Process GO:0006355 Regulation of transcription, DNA-templated
Process GO:0006357 Regulation of transcription by RNA polymerase II
Process GO:0006576 Cellular biogenic amine metabolic process
Process GO:0006584 Catecholamine metabolic process
Process GO:0006725 Cellular aromatic compound metabolic process
Process GO:0006807 Nitrogen compound metabolic process
Process GO:0006810 Transport
Process GO:0006811 Ion transport
Process GO:0006812 Cation transport
Process GO:0006816 Calcium ion transport
Process GO:0006820 Anion transport
Process GO:0006836 Neurotransmitter transport
Process GO:0006869 Lipid transport
Process GO:0006873 Cellular ion homeostasis
Process GO:0006875 Cellular metal ion homeostasis
Process GO:0006897 Endocytosis
Process GO:0006898 Receptor-mediated endocytosis
Process GO:0006914 Autophagy
Process GO:0006936 Muscle contraction
Process GO:0006939 Smooth muscle contraction
Process GO:0006950 Response to stress
Process GO:0007088 Regulation of mitotic nuclear division
Process GO:0007154 Cell communication
Process GO:0007165 Signal transduction
Process GO:0007166 Cell surface receptor signaling pathway
Process GO:0007186 G protein-coupled receptor signaling pathway
Process GO:0007188 Adenylate cyclase-modulating G protein-coupled receptor signaling pathway
Process GO:0007189 Adenylate cyclase-activating G protein-coupled receptor signaling pathway
Process GO:0007193 Adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway
Process GO:0007194 Negative regulation of adenylate cyclase activity
Process GO:0007195 Adenylate cyclase-inhibiting dopamine receptor signaling pathway
Process GO:0007200 Phospholipase C-activating G protein-coupled receptor signaling pathway
Process GO:0007204 Positive regulation of cytosolic calcium ion concentration
Process GO:0007212 Dopamine receptor signaling pathway
Process GO:0007267 Cell-cell signaling
Process GO:0007268 Chemical synaptic transmission
Process GO:0007270 Neuron-neuron synaptic transmission
Process GO:0007275 Multicellular organism development
Process GO:0007346 Regulation of mitotic cell cycle
Process GO:0007399 Nervous system development
Process GO:0007405 Neuroblast proliferation
Process GO:0007409 Axonogenesis
Process GO:0007416 Synapse assembly
Process GO:0007417 Central nervous system development
Process GO:0007420 Brain development
Process GO:0007423 Sensory organ development
Process GO:0007600 Sensory perception
Process GO:0007606 Sensory perception of chemical stimulus
Process GO:0007608 Sensory perception of smell
Process GO:0007610 Behavior
Process GO:0007611 Learning or memory
Process GO:0007612 Learning
Process GO:0007613 Memory
Process GO:0007616 Long-term memory
Process GO:0007623 Circadian rhythm
Process GO:0007625 Grooming behavior
Process GO:0007626 Locomotory behavior
Process GO:0007628 Adult walking behavior
Process GO:0007631 Feeding behavior
Process GO:0007632 Visual behavior
Process GO:0007638 Mechanosensory behavior
Process GO:0008015 Blood circulation
Process GO:0008016 Regulation of heart contraction
Process GO:0008104 Protein localization
Process GO:0008152 Metabolic process
Process GO:0008217 Regulation of blood pressure
Process GO:0008277 Regulation of G protein-coupled receptor signaling pathway
Process GO:0008283 Cell population proliferation
Process GO:0008284 Positive regulation of cell population proliferation
Process GO:0008285 Negative regulation of cell population proliferation
Process GO:0008306 Associative learning
Process GO:0008344 Adult locomotory behavior
Process GO:0008542 Visual learning
Process GO:0009056 Catabolic process
Process GO:0009308 Amine metabolic process
Process GO:0009314 Response to radiation
Process GO:0009410 Response to xenobiotic stimulus
Process GO:0009416 Response to light stimulus
Process GO:0009605 Response to external stimulus
Process GO:0009611 Response to wounding
Process GO:0009612 Response to mechanical stimulus
Process GO:0009628 Response to abiotic stimulus
Process GO:0009636 Response to toxic substance
Process GO:0009653 Anatomical structure morphogenesis
Process GO:0009712 Catechol-containing compound metabolic process
Process GO:0009719 Response to endogenous stimulus
Process GO:0009889 Regulation of biosynthetic process
Process GO:0009891 Positive regulation of biosynthetic process
Process GO:0009892 Negative regulation of metabolic process
Process GO:0009893 Positive regulation of metabolic process
Process GO:0009966 Regulation of signal transduction
Process GO:0009967 Positive regulation of signal transduction
Process GO:0009968 Negative regulation of signal transduction
Process GO:0009987 Cellular process
Process GO:0010033 Response to organic substance
Process GO:0010035 Response to inorganic substance
Process GO:0010038 Response to metal ion
Process GO:0010039 Response to iron ion
Process GO:0010243 Response to organonitrogen compound
Process GO:0010468 Regulation of gene expression
Process GO:0010556 Regulation of macromolecule biosynthetic process
Process GO:0010557 Positive regulation of macromolecule biosynthetic process
Process GO:0010562 Positive regulation of phosphorus metabolic process
Process GO:0010563 Negative regulation of phosphorus metabolic process
Process GO:0010564 Regulation of cell cycle process
Process GO:0010604 Positive regulation of macromolecule metabolic process
Process GO:0010605 Negative regulation of macromolecule metabolic process
Process GO:0010628 Positive regulation of gene expression
Process GO:0010638 Positive regulation of organelle organization
Process GO:0010646 Regulation of cell communication
Process GO:0010647 Positive regulation of cell communication
Process GO:0010648 Negative regulation of cell communication
Process GO:0010720 Positive regulation of cell development
Process GO:0010817 Regulation of hormone levels
Process GO:0010876 Lipid localization
Process GO:0010921 Regulation of phosphatase activity
Process GO:0010941 Regulation of cell death
Process GO:0010959 Regulation of metal ion transport
Process GO:0010996 Response to auditory stimulus
Process GO:0014059 Regulation of dopamine secretion
Process GO:0014070 Response to organic cyclic compound
Process GO:0014072 Response to isoquinoline alkaloid
Process GO:0014075 Response to amine
Process GO:0014821 Phasic smooth muscle contraction
Process GO:0014854 Response to inactivity
Process GO:0015711 Organic anion transport
Process GO:0015718 Monocarboxylic acid transport
Process GO:0015844 Monoamine transport
Process GO:0015849 Organic acid transport
Process GO:0015850 Organic hydroxy compound transport
Process GO:0015872 Dopamine transport
Process GO:0015908 Fatty acid transport
Process GO:0015909 Long-chain fatty acid transport
Process GO:0016043 Cellular component organization
Process GO:0016055 Wnt signaling pathway
Process GO:0016192 Vesicle-mediated transport
Process GO:0016477 Cell migration
Process GO:0017157 Regulation of exocytosis
Process GO:0018958 Phenol-containing compound metabolic process
Process GO:0019219 Regulation of nucleobase-containing compound metabolic process
Process GO:0019220 Regulation of phosphate metabolic process
Process GO:0019222 Regulation of metabolic process
Process GO:0019725 Cellular homeostasis
Process GO:0021536 Diencephalon development
Process GO:0021537 Telencephalon development
Process GO:0021544 Subpallium development
Process GO:0021756 Striatum development
Process GO:0021761 Limbic system development
Process GO:0021769 Orbitofrontal cortex development
Process GO:0021826 Substrate-independent telencephalic tangential migration
Process GO:0021830 Interneuron migration from the subpallium to the cortex
Process GO:0021843 Substrate-independent telencephalic tangential interneuron migration
Process GO:0021853 Cerebral cortex GABAergic interneuron migration
Process GO:0021885 Forebrain cell migration
Process GO:0021892 Cerebral cortex GABAergic interneuron differentiation
Process GO:0021894 Cerebral cortex GABAergic interneuron development
Process GO:0021895 Cerebral cortex neuron differentiation
Process GO:0021953 Central nervous system neuron differentiation
Process GO:0021954 Central nervous system neuron development
Process GO:0021983 Pituitary gland development
Process GO:0021984 Adenohypophysis development
Process GO:0022008 Neurogenesis
Process GO:0022029 Telencephalon cell migration
Process GO:0022401 Negative adaptation of signaling pathway
Process GO:0022607 Cellular component assembly
Process GO:0022898 Regulation of transmembrane transporter activity
Process GO:0023051 Regulation of signaling
Process GO:0023052 Signaling
Process GO:0023056 Positive regulation of signaling
Process GO:0023057 Negative regulation of signaling
Process GO:0023058 Adaptation of signaling pathway
Process GO:0030001 Metal ion transport
Process GO:0030003 Cellular cation homeostasis
Process GO:0030004 Cellular monovalent inorganic cation homeostasis
Process GO:0030007 Cellular potassium ion homeostasis
Process GO:0030030 Cell projection organization
Process GO:0030100 Regulation of endocytosis
Process GO:0030154 Cell differentiation
Process GO:0030182 Neuron differentiation
Process GO:0030334 Regulation of cell migration
Process GO:0030336 Negative regulation of cell migration
Process GO:0030432 Peristalsis
Process GO:0030534 Adult behavior
Process GO:0030900 Forebrain development
Process GO:0031175 Neuron projection development
Process GO:0031223 Auditory behavior
Process GO:0031279 Regulation of cyclase activity
Process GO:0031280 Negative regulation of cyclase activity
Process GO:0031323 Regulation of cellular metabolic process
Process GO:0031324 Negative regulation of cellular metabolic process
Process GO:0031325 Positive regulation of cellular metabolic process
Process GO:0031326 Regulation of cellular biosynthetic process
Process GO:0031328 Positive regulation of cellular biosynthetic process
Process GO:0031347 Regulation of defense response
Process GO:0031348 Negative regulation of defense response
Process GO:0031399 Regulation of protein modification process
Process GO:0031400 Negative regulation of protein modification process
Process GO:0031401 Positive regulation of protein modification process
Process GO:0031623 Receptor internalization
Process GO:0032101 Regulation of response to external stimulus
Process GO:0032102 Negative regulation of response to external stimulus
Process GO:0032147 Activation of protein kinase activity
Process GO:0032228 Regulation of synaptic transmission, GABAergic
Process GO:0032309 Icosanoid secretion
Process GO:0032409 Regulation of transporter activity
Process GO:0032410 Negative regulation of transporter activity
Process GO:0032412 Regulation of ion transmembrane transporter activity
Process GO:0032413 Negative regulation of ion transmembrane transporter activity
Process GO:0032465 Regulation of cytokinesis
Process GO:0032467 Positive regulation of cytokinesis
Process GO:0032501 Multicellular organismal process
Process GO:0032502 Developmental process
Process GO:0032879 Regulation of localization
Process GO:0032880 Regulation of protein localization
Process GO:0032922 Circadian regulation of gene expression
Process GO:0032989 Cellular component morphogenesis
Process GO:0032990 Cell part morphogenesis
Process GO:0033036 Macromolecule localization
Process GO:0033043 Regulation of organelle organization
Process GO:0033602 Negative regulation of dopamine secretion
Process GO:0033604 Negative regulation of catecholamine secretion
Process GO:0033674 Positive regulation of kinase activity
Process GO:0034220 Ion transmembrane transport
Process GO:0034329 Cell junction assembly
Process GO:0034330 Cell junction organization
Process GO:0034641 Cellular nitrogen compound metabolic process
Process GO:0034762 Regulation of transmembrane transport
Process GO:0034763 Negative regulation of transmembrane transport
Process GO:0034765 Regulation of ion transmembrane transport
Process GO:0034766 Negative regulation of ion transmembrane transport
Process GO:0034776 Response to histamine
Process GO:0035094 Response to nicotine
Process GO:0035270 Endocrine system development
Process GO:0035303 Regulation of dephosphorylation
Process GO:0035304 Regulation of protein dephosphorylation
Process GO:0035556 Intracellular signal transduction
Process GO:0035809 Regulation of urine volume
Process GO:0035810 Positive regulation of urine volume
Process GO:0035813 Regulation of renal sodium excretion
Process GO:0035815 Positive regulation of renal sodium excretion
Process GO:0036293 Response to decreased oxygen levels
Process GO:0040008 Regulation of growth
Process GO:0040012 Regulation of locomotion
Process GO:0040013 Negative regulation of locomotion
Process GO:0040014 Regulation of multicellular organism growth
Process GO:0040018 Positive regulation of multicellular organism growth
Process GO:0042127 Regulation of cell population proliferation
Process GO:0042220 Response to cocaine
Process GO:0042221 Response to chemical
Process GO:0042321 Negative regulation of circadian sleep/wake cycle, sleep
Process GO:0042325 Regulation of phosphorylation
Process GO:0042326 Negative regulation of phosphorylation
Process GO:0042327 Positive regulation of phosphorylation
Process GO:0042417 Dopamine metabolic process
Process GO:0042592 Homeostatic process
Process GO:0042749 Regulation of circadian sleep/wake cycle
Process GO:0042752 Regulation of circadian rhythm
Process GO:0042754 Negative regulation of circadian rhythm
Process GO:0042756 Drinking behavior
Process GO:0043010 Camera-type eye development
Process GO:0043085 Positive regulation of catalytic activity
Process GO:0043086 Negative regulation of catalytic activity
Process GO:0043266 Regulation of potassium ion transport
Process GO:0043269 Regulation of ion transport
Process GO:0043270 Positive regulation of ion transport
Process GO:0043271 Negative regulation of ion transport
Process GO:0043278 Response to morphine
Process GO:0043279 Response to alkaloid
Process GO:0043408 Regulation of MAPK cascade
Process GO:0043410 Positive regulation of MAPK cascade
Process GO:0043473 Pigmentation
Process GO:0043491 Protein kinase B signaling
Process GO:0043549 Regulation of kinase activity
Process GO:0043666 Regulation of phosphoprotein phosphatase activity
Process GO:0044057 Regulation of system process
Process GO:0044062 Regulation of excretion
Process GO:0044085 Cellular component biogenesis
Process GO:0044092 Negative regulation of molecular function
Process GO:0044093 Positive regulation of molecular function
Process GO:0044106 Cellular amine metabolic process
Process GO:0044237 Cellular metabolic process
Process GO:0044248 Cellular catabolic process
Process GO:0045088 Regulation of innate immune response
Process GO:0045187 Regulation of circadian sleep/wake cycle, sleep
Process GO:0045471 Response to ethanol
Process GO:0045595 Regulation of cell differentiation
Process GO:0045597 Positive regulation of cell differentiation
Process GO:0045744 Negative regulation of G protein-coupled receptor signaling pathway
Process GO:0045745 Positive regulation of G protein-coupled receptor signaling pathway
Process GO:0045761 Regulation of adenylate cyclase activity
Process GO:0045776 Negative regulation of blood pressure
Process GO:0045787 Positive regulation of cell cycle
Process GO:0045807 Positive regulation of endocytosis
Process GO:0045824 Negative regulation of innate immune response
Process GO:0045840 Positive regulation of mitotic nuclear division
Process GO:0045859 Regulation of protein kinase activity
Process GO:0045860 Positive regulation of protein kinase activity
Process GO:0045893 Positive regulation of transcription, DNA-templated
Process GO:0045927 Positive regulation of growth
Process GO:0045935 Positive regulation of nucleobase-containing compound metabolic process
Process GO:0045936 Negative regulation of phosphate metabolic process
Process GO:0045937 Positive regulation of phosphate metabolic process
Process GO:0045944 Positive regulation of transcription by RNA polymerase II
Process GO:0046676 Negative regulation of insulin secretion
Process GO:0046717 Acid secretion
Process GO:0046883 Regulation of hormone secretion
Process GO:0046887 Positive regulation of hormone secretion
Process GO:0046888 Negative regulation of hormone secretion
Process GO:0046903 Secretion
Process GO:0046928 Regulation of neurotransmitter secretion
Process GO:0046942 Carboxylic acid transport
Process GO:0048148 Behavioral response to cocaine
Process GO:0048149 Behavioral response to ethanol
Process GO:0048167 Regulation of synaptic plasticity
Process GO:0048168 Regulation of neuronal synaptic plasticity
Process GO:0048169 Regulation of long-term neuronal synaptic plasticity
Process GO:0048259 Regulation of receptor-mediated endocytosis
Process GO:0048260 Positive regulation of receptor-mediated endocytosis
Process GO:0048468 Cell development
Process GO:0048511 Rhythmic process
Process GO:0048513 Animal organ development
Process GO:0048518 Positive regulation of biological process
Process GO:0048519 Negative regulation of biological process
Process GO:0048521 Negative regulation of behavior
Process GO:0048522 Positive regulation of cellular process
Process GO:0048523 Negative regulation of cellular process
Process GO:0048583 Regulation of response to stimulus
Process GO:0048584 Positive regulation of response to stimulus
Process GO:0048585 Negative regulation of response to stimulus
Process GO:0048638 Regulation of developmental growth
Process GO:0048639 Positive regulation of developmental growth
Process GO:0048666 Neuron development
Process GO:0048667 Cell morphogenesis involved in neuron differentiation
Process GO:0048678 Response to axon injury
Process GO:0048699 Generation of neurons
Process GO:0048731 System development
Process GO:0048732 Gland development
Process GO:0048755 Branching morphogenesis of a nerve
Process GO:0048812 Neuron projection morphogenesis
Process GO:0048856 Anatomical structure development
Process GO:0048858 Cell projection morphogenesis
Process GO:0048869 Cellular developmental process
Process GO:0048870 Cell motility
Process GO:0048871 Multicellular organismal homeostasis
Process GO:0048878 Chemical homeostasis
Process GO:0048880 Sensory system development
Process GO:0050433 Regulation of catecholamine secretion
Process GO:0050482 Arachidonic acid secretion
Process GO:0050673 Epithelial cell proliferation
Process GO:0050678 Regulation of epithelial cell proliferation
Process GO:0050680 Negative regulation of epithelial cell proliferation
Process GO:0050708 Regulation of protein secretion
Process GO:0050709 Negative regulation of protein secretion
Process GO:0050767 Regulation of neurogenesis
Process GO:0050769 Positive regulation of neurogenesis
Process GO:0050776 Regulation of immune response
Process GO:0050777 Negative regulation of immune response
Process GO:0050789 Regulation of biological process
Process GO:0050790 Regulation of catalytic activity
Process GO:0050793 Regulation of developmental process
Process GO:0050794 Regulation of cellular process
Process GO:0050795 Regulation of behavior
Process GO:0050796 Regulation of insulin secretion
Process GO:0050801 Ion homeostasis
Process GO:0050803 Regulation of synapse structure or activity
Process GO:0050804 Modulation of chemical synaptic transmission
Process GO:0050805 Negative regulation of synaptic transmission
Process GO:0050806 Positive regulation of synaptic transmission
Process GO:0050807 Regulation of synapse organization
Process GO:0050808 Synapse organization
Process GO:0050877 Nervous system process
Process GO:0050878 Regulation of body fluid levels
Process GO:0050890 Cognition
Process GO:0050896 Response to stimulus
Process GO:0050905 Neuromuscular process
Process GO:0051046 Regulation of secretion
Process GO:0051047 Positive regulation of secretion
Process GO:0051048 Negative regulation of secretion
Process GO:0051049 Regulation of transport
Process GO:0051050 Positive regulation of transport
Process GO:0051051 Negative regulation of transport
Process GO:0051094 Positive regulation of developmental process
Process GO:0051128 Regulation of cellular component organization
Process GO:0051130 Positive regulation of cellular component organization
Process GO:0051171 Regulation of nitrogen compound metabolic process
Process GO:0051172 Negative regulation of nitrogen compound metabolic process
Process GO:0051173 Positive regulation of nitrogen compound metabolic process
Process GO:0051174 Regulation of phosphorus metabolic process
Process GO:0051179 Localization
Process GO:0051209 Release of sequestered calcium ion into cytosol
Process GO:0051223 Regulation of protein transport
Process GO:0051224 Negative regulation of protein transport
Process GO:0051234 Establishment of localization
Process GO:0051239 Regulation of multicellular organismal process
Process GO:0051240 Positive regulation of multicellular organismal process
Process GO:0051241 Negative regulation of multicellular organismal process
Process GO:0051246 Regulation of protein metabolic process
Process GO:0051247 Positive regulation of protein metabolic process
Process GO:0051248 Negative regulation of protein metabolic process
Process GO:0051252 Regulation of RNA metabolic process
Process GO:0051254 Positive regulation of RNA metabolic process
Process GO:0051282 Regulation of sequestering of calcium ion
Process GO:0051283 Negative regulation of sequestering of calcium ion
Process GO:0051302 Regulation of cell division
Process GO:0051336 Regulation of hydrolase activity
Process GO:0051338 Regulation of transferase activity
Process GO:0051339 Regulation of lyase activity
Process GO:0051347 Positive regulation of transferase activity
Process GO:0051350 Negative regulation of lyase activity
Process GO:0051481 Negative regulation of cytosolic calcium ion concentration
Process GO:0051482 Positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway
Process GO:0051580 Regulation of neurotransmitter uptake
Process GO:0051582 Positive regulation of neurotransmitter uptake
Process GO:0051583 Dopamine uptake involved in synaptic transmission
Process GO:0051584 Regulation of dopamine uptake involved in synaptic transmission
Process GO:0051586 Positive regulation of dopamine uptake involved in synaptic transmission
Process GO:0051588 Regulation of neurotransmitter transport
Process GO:0051590 Positive regulation of neurotransmitter transport
Process GO:0051641 Cellular localization
Process GO:0051649 Establishment of localization in cell
Process GO:0051716 Cellular response to stimulus
Process GO:0051726 Regulation of cell cycle
Process GO:0051781 Positive regulation of cell division
Process GO:0051783 Regulation of nuclear division
Process GO:0051785 Positive regulation of nuclear division
Process GO:0051823 Regulation of synapse structural plasticity
Process GO:0051896 Regulation of protein kinase B signaling
Process GO:0051898 Negative regulation of protein kinase B signaling
Process GO:0051924 Regulation of calcium ion transport
Process GO:0051926 Negative regulation of calcium ion transport
Process GO:0051934 Catecholamine uptake involved in synaptic transmission
Process GO:0051937 Catecholamine transport
Process GO:0051940 Regulation of catecholamine uptake involved in synaptic transmission
Process GO:0051944 Positive regulation of catecholamine uptake involved in synaptic transmission
Process GO:0051952 Regulation of amine transport
Process GO:0051953 Negative regulation of amine transport
Process GO:0051954 Positive regulation of amine transport
Process GO:0051960 Regulation of nervous system development
Process GO:0051962 Positive regulation of nervous system development
Process GO:0051966 Regulation of synaptic transmission, glutamatergic
Process GO:0051967 Negative regulation of synaptic transmission, glutamatergic
Process GO:0055065 Metal ion homeostasis
Process GO:0055067 Monovalent inorganic cation homeostasis
Process GO:0055075 Potassium ion homeostasis
Process GO:0055080 Cation homeostasis
Process GO:0055082 Cellular chemical homeostasis
Process GO:0055085 Transmembrane transport
Process GO:0060033 Anatomical structure regression
Process GO:0060123 Regulation of growth hormone secretion
Process GO:0060124 Positive regulation of growth hormone secretion
Process GO:0060134 Prepulse inhibition
Process GO:0060158 Phospholipase C-activating dopamine receptor signaling pathway
Process GO:0060159 Regulation of dopamine receptor signaling pathway
Process GO:0060160 Negative regulation of dopamine receptor signaling pathway
Process GO:0060255 Regulation of macromolecule metabolic process
Process GO:0060284 Regulation of cell development
Process GO:0060322 Head development
Process GO:0060341 Regulation of cellular localization
Process GO:0060548 Negative regulation of cell death
Process GO:0060627 Regulation of vesicle-mediated transport
Process GO:0061351 Neural precursor cell proliferation
Process GO:0061564 Axon development
Process GO:0061919 Process utilizing autophagic mechanism
Process GO:0065007 Biological regulation
Process GO:0065008 Regulation of biological quality
Process GO:0065009 Regulation of molecular function
Process GO:0070201 Regulation of establishment of protein localization
Process GO:0070372 Regulation of ERK1 and ERK2 cascade
Process GO:0070374 Positive regulation of ERK1 and ERK2 cascade
Process GO:0070482 Response to oxygen levels
Process GO:0070588 Calcium ion transmembrane transport
Process GO:0070727 Cellular macromolecule localization
Process GO:0070887 Cellular response to chemical stimulus
Process GO:0071310 Cellular response to organic substance
Process GO:0071407 Cellular response to organic cyclic compound
Process GO:0071417 Cellular response to organonitrogen compound
Process GO:0071495 Cellular response to endogenous stimulus
Process GO:0071702 Organic substance transport
Process GO:0071704 Organic substance metabolic process
Process GO:0071705 Nitrogen compound transport
Process GO:0071715 Icosanoid transport
Process GO:0071840 Cellular component organization or biogenesis
Process GO:0071867 Response to monoamine
Process GO:0071868 Cellular response to monoamine stimulus
Process GO:0071869 Response to catecholamine
Process GO:0071870 Cellular response to catecholamine stimulus
Process GO:0071875 Adrenergic receptor signaling pathway
Process GO:0071880 Adenylate cyclase-activating adrenergic receptor signaling pathway
Process GO:0080090 Regulation of primary metabolic process
Process GO:0080134 Regulation of response to stress
Process GO:0090068 Positive regulation of cell cycle process
Process GO:0090087 Regulation of peptide transport
Process GO:0090276 Regulation of peptide hormone secretion
Process GO:0090277 Positive regulation of peptide hormone secretion
Process GO:0090278 Negative regulation of peptide hormone secretion
Process GO:0090325 Regulation of locomotion involved in locomotory behavior
Process GO:0090493 Catecholamine uptake
Process GO:0090494 Dopamine uptake
Process GO:0090659 Walking behavior
Process GO:0097154 GABAergic neuron differentiation
Process GO:0097305 Response to alcohol
Process GO:0097553 Calcium ion transmembrane import into cytosol
Process GO:0098655 Cation transmembrane transport
Process GO:0098657 Import into cell
Process GO:0098660 Inorganic ion transmembrane transport
Process GO:0098662 Inorganic cation transmembrane transport
Process GO:0098771 Inorganic ion homeostasis
Process GO:0098801 Regulation of renal system process
Process GO:0098810 Neurotransmitter reuptake
Process GO:0098916 Anterograde trans-synaptic signaling
Process GO:0099170 Postsynaptic modulation of chemical synaptic transmission
Process GO:0099177 Regulation of trans-synaptic signaling
Process GO:0099536 Synaptic signaling
Process GO:0099537 Trans-synaptic signaling
Process GO:0099565 Chemical synaptic transmission, postsynaptic
Process GO:0120036 Plasma membrane bounded cell projection organization
Process GO:0120039 Plasma membrane bounded cell projection morphogenesis
Process GO:0150063 Visual system development
Process GO:0198738 Cell-cell signaling by wnt
Process GO:1900166 Regulation of glial cell-derived neurotrophic factor production
Process GO:1900168 Positive regulation of glial cell-derived neurotrophic factor production
Process GO:1900271 Regulation of long-term synaptic potentiation
Process GO:1900273 Positive regulation of long-term synaptic potentiation
Process GO:1901019 Regulation of calcium ion transmembrane transporter activity
Process GO:1901020 Negative regulation of calcium ion transmembrane transporter activity
Process GO:1901360 Organic cyclic compound metabolic process
Process GO:1901385 Regulation of voltage-gated calcium channel activity
Process GO:1901386 Negative regulation of voltage-gated calcium channel activity
Process GO:1901564 Organonitrogen compound metabolic process
Process GO:1901615 Organic hydroxy compound metabolic process
Process GO:1901698 Response to nitrogen compound
Process GO:1901699 Cellular response to nitrogen compound
Process GO:1901700 Response to oxygen-containing compound
Process GO:1901701 Cellular response to oxygen-containing compound
Process GO:1902531 Regulation of intracellular signal transduction
Process GO:1902532 Negative regulation of intracellular signal transduction
Process GO:1902533 Positive regulation of intracellular signal transduction
Process GO:1902680 Positive regulation of RNA biosynthetic process
Process GO:1902692 Regulation of neuroblast proliferation
Process GO:1903169 Regulation of calcium ion transmembrane transport
Process GO:1903170 Negative regulation of calcium ion transmembrane transport
Process GO:1903305 Regulation of regulated secretory pathway
Process GO:1903350 Response to dopamine
Process GO:1903351 Cellular response to dopamine
Process GO:1903506 Regulation of nucleic acid-templated transcription
Process GO:1903508 Positive regulation of nucleic acid-templated transcription
Process GO:1903522 Regulation of blood circulation
Process GO:1903530 Regulation of secretion by cell
Process GO:1903531 Negative regulation of secretion by cell
Process GO:1903532 Positive regulation of secretion by cell
Process GO:1903828 Negative regulation of protein localization
Process GO:1903963 Arachidonate transport
Process GO:1904062 Regulation of cation transmembrane transport
Process GO:1904063 Negative regulation of cation transmembrane transport
Process GO:1904936 Interneuron migration
Process GO:1904950 Negative regulation of establishment of protein localization
Process GO:1905114 Cell surface receptor signaling pathway involved in cell-cell signaling
Process GO:1990384 Hyaloid vascular plexus regression
Process GO:2000026 Regulation of multicellular organismal development
Process GO:2000145 Regulation of cell motility
Process GO:2000146 Negative regulation of cell motility
Process GO:2000177 Regulation of neural precursor cell proliferation
Process GO:2000179 Positive regulation of neural precursor cell proliferation
Process GO:2000300 Regulation of synaptic vesicle exocytosis
Process GO:2001141 Regulation of RNA biosynthetic process
Process GO:2001222 Regulation of neuron migration
Process GO:2001223 Negative regulation of neuron migration
Process GO:2001257 Regulation of cation channel activity
Process GO:2001258 Negative regulation of cation channel activity
Component GO:0000139 Golgi membrane
Component GO:0001669 Acrosomal vesicle
Component GO:0005622 Intracellular anatomical structure
Component GO:0005737 Cytoplasm
Component GO:0005794 Golgi apparatus
Component GO:0005886 Plasma membrane
Component GO:0005887 Integral component of plasma membrane
Component GO:0005929 Cilium
Component GO:0008021 Synaptic vesicle
Component GO:0012505 Endomembrane system
Component GO:0012506 Vesicle membrane
Component GO:0014069 Postsynaptic density
Component GO:0016020 Membrane
Component GO:0016021 Integral component of membrane
Component GO:0016328 Lateral plasma membrane
Component GO:0030054 Cell junction
Component GO:0030133 Transport vesicle
Component GO:0030139 Endocytic vesicle
Component GO:0030141 Secretory granule
Component GO:0030424 Axon
Component GO:0030425 Dendrite
Component GO:0030658 Transport vesicle membrane
Component GO:0030659 Cytoplasmic vesicle membrane
Component GO:0030672 Synaptic vesicle membrane
Component GO:0031090 Organelle membrane
Component GO:0031224 Intrinsic component of membrane
Component GO:0031226 Intrinsic component of plasma membrane
Component GO:0031253 Cell projection membrane
Component GO:0031410 Cytoplasmic vesicle
Component GO:0031514 Motile cilium
Component GO:0031982 Vesicle
Component GO:0032279 Asymmetric synapse
Component GO:0036126 Sperm flagellum
Component GO:0036477 Somatodendritic compartment
Component GO:0042734 Presynaptic membrane
Component GO:0042995 Cell projection
Component GO:0043005 Neuron projection
Component GO:0043025 Neuronal cell body
Component GO:0043197 Dendritic spine
Component GO:0043204 Perikaryon
Component GO:0043226 Organelle
Component GO:0043227 Membrane-bounded organelle
Component GO:0043229 Intracellular organelle
Component GO:0043231 Intracellular membrane-bounded organelle
Component GO:0043679 Axon terminus
Component GO:0044297 Cell body
Component GO:0044306 Neuron projection terminus
Component GO:0044309 Neuron spine
Component GO:0045202 Synapse
Component GO:0045211 Postsynaptic membrane
Component GO:0060170 Ciliary membrane
Component GO:0070382 Exocytic vesicle
Component GO:0071944 Cell periphery
Component GO:0097060 Synaptic membrane
Component GO:0097447 Dendritic tree
Component GO:0097708 Intracellular vesicle
Component GO:0097729 9+2 motile cilium
Component GO:0097730 Non-motile cilium
Component GO:0098588 Bounding membrane of organelle
Component GO:0098590 Plasma membrane region
Component GO:0098691 Dopaminergic synapse
Component GO:0098793 Presynapse
Component GO:0098794 Postsynapse
Component GO:0098889 Intrinsic component of presynaptic membrane
Component GO:0098936 Intrinsic component of postsynaptic membrane
Component GO:0098978 Glutamatergic synapse
Component GO:0098982 GABA-ergic synapse
Component GO:0098984 Neuron to neuron synapse
Component GO:0099055 Integral component of postsynaptic membrane
Component GO:0099056 Integral component of presynaptic membrane
Component GO:0099240 Intrinsic component of synaptic membrane
Component GO:0099501 Exocytic vesicle membrane
Component GO:0099503 Secretory vesicle
Component GO:0099572 Postsynaptic specialization
Component GO:0099699 Integral component of synaptic membrane
Component GO:0110165 Cellular anatomical entity
Component GO:0120025 Plasma membrane bounded cell projection
Component GO:0150034 Distal axon
Function GO:0001591 Dopamine neurotransmitter receptor activity, coupled via Gi/Go
Function GO:0004888 Transmembrane signaling receptor activity
Function GO:0004930 G protein-coupled receptor activity
Function GO:0004952 Dopamine neurotransmitter receptor activity
Function GO:0005102 Signaling receptor binding
Function GO:0005488 Binding
Function GO:0005515 Protein binding
Function GO:0030594 Neurotransmitter receptor activity
Function GO:0035240 Dopamine binding
Function GO:0035254 Glutamate receptor binding
Function GO:0035255 Ionotropic glutamate receptor binding
Function GO:0038023 Signaling receptor activity
Function GO:0042802 Identical protein binding
Function GO:0043167 Ion binding
Function GO:0043169 Cation binding
Function GO:0044877 Protein-containing complex binding
Function GO:0060089 Molecular transducer activity
Function GO:0097159 Organic cyclic compound binding
Function GO:0098960 Postsynaptic neurotransmitter receptor activity
Function GO:1901338 Catecholamine binding
Function GO:1901363 Heterocyclic compound binding

Pathway annotation


Category Term ID Term description
RCTM RNO-162582 Signal Transduction
RCTM RNO-372790 Signaling by GPCR
RCTM RNO-373076 Class A/1 (Rhodopsin-like receptors)
RCTM RNO-375280 Amine ligand-binding receptors
RCTM RNO-390651 Dopamine receptors
RCTM RNO-500792 GPCR ligand binding

Expression profile of Drd2 in omics data



ID GSE100499
Title Exploring acupuncture mechanism in preconditioning of IRI
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM2685201 MX1 tissue: Myocardium gender: male 5.39942315
GSM2685202 MX2 tissue: Myocardium gender: female 5.3911408000000005
GSM2685203 MX3 tissue: Myocardium gender: female 5.08202895
GSM2685204 MX4 tissue: Myocardium gender: male 5.08217335
GSM2685205 DZ1 tissue: Myocardium gender: male 5.5434845
GSM2685206 DZ2 tissue: Myocardium gender: male 4.784384
GSM2685207 DZ3 tissue: Myocardium gender: female 5.3882735
GSM2685208 DZ4 tissue: Myocardium gender: female 5.31677235
GSM2685209 JJ1 tissue: Myocardium gender: male 5.6313585
GSM2685210 JJ2 tissue: Myocardium gender: female 5.16548735
GSM2685211 JJ3 tissue: Myocardium gender: female 5.6621597999999995
GSM2685212 JJ4 tissue: Myocardium gender: male 5.2850795
GSM2685213 NG1 tissue: Myocardium gender: male 5.4678356
GSM2685214 NG2 tissue: Myocardium gender: female 4.9592234
GSM2685215 NG3 tissue: Myocardium gender: male 5.41798285
GSM2685216 NG4 tissue: Myocardium gender: female 5.0844404999999995
GSM2685217 YL1 tissue: Myocardium gender: male 5.0509373
GSM2685218 YL2 tissue: Myocardium gender: male 4.9906127
GSM2685219 YL3 tissue: Myocardium gender: female 5.28238535
GSM2685220 YL4 tissue: Myocardium gender: female 5.3469082
GSM2685221 QC1 tissue: Myocardium gender: male 5.160761
GSM2685222 QC2 tissue: Myocardium gender: male 5.76750875
GSM2685223 QC3 tissue: Myocardium gender: female 5.570442
GSM2685224 QC4 tissue: Myocardium gender: female 5.4338666

ID GSE136833
Title Effects of lidocaine on the expression of rat spinal cord
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4058984 Control_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 5.913634778
GSM4058985 Control_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 6.121057837
GSM4058986 Control_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 5.978805677
GSM4058987 Lidocaine_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 5.621424791
GSM4058988 Lidocaine_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 5.671534137
GSM4058989 Lidocaine_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 5.282003502

ID GSE138454
Title Impact of inflammation on hepatic subcellular energetics in anesthetized rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4108997 Sample 1 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4108998 Sample 2 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4108999 Sample 3 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4109000 Sample 4 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4109001 Sample 5 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109002 Sample 6 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 1.0
GSM4109003 Sample 7 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 1.0
GSM4109004 Sample 8 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109005 Sample9 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 1.0
GSM4109006 Sample10 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 3.0
GSM4109007 Sample11 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4109008 Sample12 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 1.0
GSM4109009 Sample13 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109010 Sample14 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109011 Sample 15 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109012 Sample16 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 1.0

ID GSE139220
Title Expression data from sevoflurane anesthesia treated rat
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4134285 Brain_Control_rep1 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 6.108598
GSM4134286 Brain_Control_rep2 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 6.441239
GSM4134287 Brain_Control_rep3 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 6.30156
GSM4134288 Brain_Sevoflurane_rep1 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.511942
GSM4134289 Brain_Sevoflurane_rep2 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.339022
GSM4134290 Brain_Sevoflurane_rep3 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.10239

ID GSE143895
Title GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4276356 dhsc01 strain: Sprague Dawley tissue: DHSC treatment: CCI 9.255
GSM4276357 dhsc03 strain: Sprague Dawley tissue: DHSC treatment: CCI 10.925
GSM4276358 dhsc05 strain: Sprague Dawley tissue: DHSC treatment: CCI 10.529
GSM4276359 dhsc13 strain: Sprague Dawley tissue: DHSC treatment: SHAM 8.007
GSM4276360 dhsc15 strain: Sprague Dawley tissue: DHSC treatment: SHAM 10.506

ID GSE157924
Title Regulation of acupuncture on genes in brain stem
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4780973 Rattus_JSSZ(Sham) tissue: Rattus brainstem of modeling treatment: Sham 8.404462509
GSM4780974 Rattus_JXZ(Hand Acu) tissue: Rattus brainstem of modeling treatment: Hand Acu 8.637613011
GSM4780975 Rattus_MXZ(TBI) tissue: Rattus brainstem of modeling treatment: TBI 8.661200805

ID GSE1616
Title Genomics of preconditioning
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM27484 APC_a (anesthetic-preconditioning, 1st replicate) 43.4
GSM27485 APC_b (anesthetic-preconditioning, 2nd replicate) 30.9
GSM27486 APC_c (anesthetic-preconditioning, 3rd replicate) 33.3
GSM27487 APC_d (anesthetic-preconditioning, 4th replicate) 27.4
GSM27488 APC_e (anesthetic-preconditioning, 5th replicate) 25.2
GSM27489 APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate) 43.0
GSM27490 APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate) 41.0
GSM27491 APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate) 29.9
GSM27492 APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate) 40.1
GSM27493 APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate) 50.5
GSM27494 CTL_a (control, 1st replicate) 22.2
GSM27495 CTL_b (control, 2nd replicate) 23.5
GSM27496 CTL_c (control, 3rd replicate) 43.0
GSM27497 CTL_d (control, 4th replicate) 24.6
GSM27498 CTL_e (control, 5th replicate) 86.0
GSM27499 IPC_a (ischemic preconditioning, 1st replicate) 38.5
GSM27500 IPC_b (ischemic preconditioning, 2nd replicate) 21.8
GSM27501 IPC_c (ischemic preconditioning, 3rd replicate) 25.4
GSM27502 IPC_d (ischemic preconditioning, 4th replicate) 23.7
GSM27503 IPC_e (ischemic preconditioning, 5th replicate) 27.9
GSM27504 IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate) 54.0
GSM27505 IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate) 38.4
GSM27506 IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate) 92.0
GSM27507 IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate) 33.5
GSM27508 IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate) 70.9
GSM27509 ISCH_a (ischemia, 1st replicate) 48.6
GSM27510 ISCH_b (ischemia, 2nd replicate) 27.3
GSM27511 ISCH_c (ischemia, 3rd replicate) 33.2
GSM27512 ISCH_d (ischemia, 4th replicate) 22.4
GSM27513 ISCH_e (ischemia, 5th replicate) 38.4

ID GSE1779
Title Effect of Isoflurane and LTM on basolateral amygdala
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM30790 baseline control 01 male, 275-300g 304.6
GSM30791 baseline control 02 male, 275-300g 393.9
GSM30792 baseline control 03 male, 275-300g 545.9
GSM30793 baseline control 04 male, 275-300g 225.7
GSM30794 baseline control 05 male, 275-300g 254.4
GSM30795 baseline control 06 male, 275-300g 167.2
GSM30796 baseline control 07 male, 275-300g 180.8
GSM30797 baseline control 08 male, 275-300g 203.1
GSM30798 baseline control 09 male, 275-300g 133.1
GSM30799 pain 01 78.6
GSM30800 pain 02 412.7
GSM30801 pain 03 199.7
GSM30802 pain 04 168.8
GSM30803 pain 05 238.3
GSM30804 FC 01 127.5
GSM30805 FC 02 195.4
GSM30806 FC 03 141.8
GSM30807 FC 04 324.9
GSM30808 FC 05 113.1
GSM30809 IFC 01 259.5
GSM30810 IFC 02 272.2
GSM30811 IFC 03 149.7
GSM30812 IFC 04 218.6
GSM30813 IFC 05 185.4
GSM99800 isoflurane 01 male, 275-300g 188.5
GSM99801 isoflurane 02 male, 275-300g 152.4
GSM99802 isoflurane 03 male, 275-300g 212.2
GSM99803 isoflurane 04 male, 275-300g 172.9
GSM99804 isoflurane 05 male, 275-300g 268.7

ID GSE190472
Title Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5724271 model 21 Sex: female tissue: Uterine tissue condition: model 12.5543
GSM5724272 model 22 Sex: female tissue: Uterine tissue condition: model 8.5154
GSM5724273 model 23 Sex: female tissue: Uterine tissue condition: model 8.8579
GSM5724274 treatment31 Sex: female tissue: Uterine tissue condition: treatment 10.0677
GSM5724275 treatment32 Sex: female tissue: Uterine tissue condition: treatment 10.9035
GSM5724276 treatment33 Sex: female tissue: Uterine tissue condition: treatment 9.7033
GSM5724277 control 41 Sex: female tissue: Uterine tissue condition: control 8.346
GSM5724278 control 42 Sex: female tissue: Uterine tissue condition: control 9.1553
GSM5724279 control 43 Sex: female tissue: Uterine tissue condition: control 6.8053

ID GSE192399
Title Gene expression of brain regions activated by sevoflurane and propofol
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5746332 LHb, Sevoflurane, 60mins brain region: the lateral habenula (LHb) treatment: Sevoflurane 5.23843
GSM5746333 LHb, O2, 60mins brain region: the lateral habenula (LHb) treatment: O2 4.93201
GSM5746334 MHb, Sevoflurane, 60mins brain region: the medial habenula (MHb) treatment: Sevoflurane 4.01642
GSM5746335 MHb, O2, 60mins brain region: the medial habenula (MHb) treatment: O2 4.06751
GSM5746336 Sol, Sevoflurane, 60mins brain region: the solitary nucleus (Sol) treatment: Sevoflurane 6.84947
GSM5746337 Sol, O2, 60mins brain region: the solitary nucleus (Sol) treatment: O2 6.26732
GSM5746338 Mve, Sevoflurane, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane 5.10851
GSM5746339 Mve, O2, 60mins brain region: the medial vestibular nucleus (MVe) treatment: O2 4.69478
GSM5746340 LHb, Propofol, 60mins brain region: the lateral habenula (LHb) treatment: Propofol 4.3735
GSM5746341 LHb, Intralipos, 60mins brain region: the lateral habenula (LHb) treatment: Intralipos 4.37898
GSM5746342 MHb, Propofol, 60mins brain region: the medial habenula (MHb) treatment: Propofol 4.26771
GSM5746343 MHb, Intralipos, 60mins brain region: the medial habenula (MHb) treatment: Intralipos 4.09483
GSM5746344 Sol, Propofol, 60mins brain region: the solitary nucleus (Sol) treatment: Propofol 5.60039
GSM5746345 Sol, Intralipos, 60mins brain region: the solitary nucleus (Sol) treatment: Intralipos 5.71738
GSM5746346 MVe, Propofol, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Propofol 4.78367
GSM5746347 MVe, Intralipos, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Intralipos 4.54044

ID GSE205202
Title Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat]
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM6208507 Rat_Baseline_0h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 6.837386
GSM6208508 Rat_Baseline_0h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 7.0514
GSM6208509 Rat_Baseline_0h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 6.767109
GSM6208510 Rat_Baseline_0h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 6.855753
GSM6208511 Rat_Baseline_0h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 7.086677
GSM6208512 Rat_Vehicle_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 6.730149
GSM6208513 Rat_Vehicle_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 6.91682
GSM6208514 Rat_Vehicle_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 6.987232
GSM6208515 Rat_Vehicle_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 6.788902
GSM6208516 Rat_Vehicle_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 6.718337
GSM6208517 Rat_Vehicle_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 6.733899
GSM6208518 Rat_Vehicle_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 6.960262
GSM6208519 Rat_Vehicle_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 7.030996
GSM6208520 Rat_Vehicle_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 6.754555
GSM6208521 Rat_Vehicle_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 6.984501
GSM6208522 Rat_Vehicle_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 6.783172
GSM6208523 Rat_Vehicle_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 6.807409
GSM6208524 Rat_Vehicle_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 7.07348
GSM6208525 Rat_Vehicle_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 6.868689
GSM6208526 Rat_Vehicle_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 6.956785
GSM6208527 Rat_Vehicle_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 6.89888
GSM6208528 Rat_Vehicle_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 6.985762
GSM6208529 Rat_Vehicle_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 6.948862
GSM6208530 Rat_Vehicle_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 6.909422
GSM6208531 Rat_Vehicle_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 6.692151
GSM6208532 Rat_APAP_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 6.767604
GSM6208533 Rat_APAP_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 6.935187
GSM6208534 Rat_APAP_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 6.780478
GSM6208535 Rat_APAP_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 6.851596
GSM6208536 Rat_APAP_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 6.792331
GSM6208537 Rat_APAP_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 6.775524
GSM6208538 Rat_APAP_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 6.641614
GSM6208539 Rat_APAP_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 6.79244
GSM6208540 Rat_APAP_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 6.623099
GSM6208541 Rat_APAP_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 6.930759
GSM6208542 Rat_APAP_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 6.594938
GSM6208543 Rat_APAP_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 6.665947
GSM6208544 Rat_APAP_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 6.976805
GSM6208545 Rat_APAP_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 6.910691
GSM6208546 Rat_APAP_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 6.638381
GSM6208547 Rat_APAP_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 6.898941
GSM6208548 Rat_APAP_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 7.172286
GSM6208549 Rat_APAP_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 6.570738
GSM6208550 Rat_APAP_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 6.837162
GSM6208551 Rat_APAP_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 6.80356

ID GSE232804
Title EGR3 regulates opioid-related nociception and motivation in male rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7383519 ww01_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 49.0
GSM7383520 ww02_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 42.0
GSM7383521 ww03_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 58.0
GSM7383522 ww05_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 45.0
GSM7383523 ww06_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 51.0
GSM7383524 ww07_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 31.0
GSM7383525 ww08_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 48.0
GSM7383526 ww10_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 26.0
GSM7383527 ww12_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 28.0
GSM7383528 ww13_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 58.0
GSM7383529 ww14_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 50.0
GSM7383530 ww15_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 37.0
GSM7383531 ww16_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 34.0
GSM7383532 ww17_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 62.0
GSM7383533 ww18_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 44.0
GSM7383534 ww20_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 42.0
GSM7383535 ww21_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 49.0
GSM7383536 ww22_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 51.0
GSM7383537 ww23_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 24.0
GSM7383538 ww24_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 37.0
GSM7383539 ww26_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 50.0
GSM7383540 ww27_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 40.0
GSM7383541 ww28_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 39.0
GSM7383542 ww30_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 27.0
GSM7383543 ww31_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 32.0
GSM7383544 ww32_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 13.0
GSM7383545 ww34_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 37.0
GSM7383546 ww35_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 54.0
GSM7383547 ww36_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 48.0
GSM7383548 ww37_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 45.0
GSM7383549 ww38_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 51.0
GSM7383550 www09_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 36.0
GSM7383551 www19_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 42.0
GSM7383552 www29_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 33.0
GSM7383553 www33_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 63.0
GSM7383554 www39_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 39.0

ID GSE2982
Title Effect of inhaled anesthetic to cultured cortical neurons
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM61779 Cell Culture Exposure (control1) Cy3 label;Cy5; 0.0683
GSM61796 Cell Culture Exposure (control2) Cy3; Cy5 0.000775
GSM61797 Cell Culture Exposure (control3) Cy3; Cy5 -0.266
GSM61798 Cell Culture Exposure (1MAC Halo1) Cy3; Cy5 -0.122
GSM61799 Cell Culture Exposure (1MAC Halo2) Cy3; Cy5 -0.0449
GSM61800 Cell Culture Exposure (1MAC Halo3) Cy3; Cy5 -0.0592
GSM61801 Cell Culture Exposure (3MAC Halo1) Cy3; Cy5 -0.0237
GSM61802 Cell Culture Exposure (3MAC Halo2) Cy3; Cy5 -0.103
GSM61803 Cell Culture Exposure (3MAC Halo3) Cy3; Cy5 -0.0281
GSM61804 Cell Culture Exposure (3MAC ISO1) Cy3; Cy5 -0.397
GSM61805 Cell Culture Exposure (3MAC ISO2) Cy3; Cy5 -0.408
GSM61806 Cell Culture Exposure (3MAC ISO3) Cy3; Cy5 -0.384

ID GSE359
Title Isoflurane Single Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5120 Isoflurane single exposure control-1 17.6
GSM5121 Isoflurane single exposure control-2 8.7
GSM5122 Isoflurane single exposure control-3 14.8
GSM5124 Isoflurane single exposure 1 hr-1 15.5
GSM5126 Isoflurane single exposure 1 hr-2 27.5
GSM5127 Isoflurane single exposure 2 hr-1 8.9
GSM5130 Isoflurane single exposure 2 hr-2 124.1
GSM5131 Isoflurane single exposure 2 hr-3 8.7

ID GSE48025
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 4.082543769
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 4.151437772
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 4.009842999
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 4.137502487
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.964308112
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 4.053651966
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 4.480997823
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 4.120192764
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.903740575
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.911877592
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 4.433907646
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 3.80143944
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 4.12483102
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 4.314593509
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 4.230410848
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 4.233770416
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 4.653053949
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 4.538695407
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 4.353894056
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 4.035943274
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 4.199331469
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 4.263837093
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 4.077122793
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 4.308687815

ID GSE53897
Title Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1303240 DRG RVM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.984334
GSM1303241 DRG RVM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.985533
GSM1303242 DRG RVM3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.916686
GSM1303243 DRG RVM7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.812652
GSM1303244 DRG RVOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.802299
GSM1303245 DRG RVOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.017552
GSM1303246 DRG RVOx5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.922582
GSM1303247 DRG RVOx7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.912931
GSM1303248 DRG RVS4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.012682
GSM1303249 DRG RVS5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.927304
GSM1303250 DRG RVS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.881329
GSM1303251 DRG RVS7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.966008
GSM1303252 DRG RSM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.018866
GSM1303253 DRG RSM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.877906
GSM1303254 DRG RSM4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.981328
GSM1303255 DRG RSM5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.018337
GSM1303256 DRG RSOx1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.936427
GSM1303257 DRG RSOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.967339
GSM1303258 DRG RSOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.111666
GSM1303259 DRG RSOx4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.171009
GSM1303260 DRG RSS1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.827111
GSM1303261 DRG RSS2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.002067
GSM1303262 DRG RSS3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.83785
GSM1303263 DRG RSS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.00899

ID GSE55573
Title Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1339443 Mock skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 370.644
GSM1339444 EA (electroacupuncture) skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 356.4833

ID GSE58456
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 5.563578357
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 21.8939592
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 21.98312362
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 6.350007724
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 34.84390651
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 30.69238734
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 105.8143308
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 21.73025092
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 10.22464527
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 42.14856346
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 13.03096169
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 14.2447772
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 12.94485497
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 4.489789977

ID GSE58460
Title Rheumatoid Arthritis Rat Model Treated with Acupuncture
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 4.082543769
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 4.151437772
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 4.009842999
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 4.137502487
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.964308112
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 4.053651966
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 4.480997823
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 4.120192764
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.903740575
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.911877592
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 4.433907646
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 3.80143944
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 4.12483102
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 4.314593509
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 4.230410848
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 4.233770416
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 4.653053949
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 4.538695407
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 4.353894056
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 4.035943274
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 4.199331469
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 4.263837093
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 4.077122793
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 4.308687815
GSM1412003 RAT_NORA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412004 RAT_NORA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412005 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412006 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412007 RAT_NORA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412008 RAT_NORA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412009 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412010 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412011 RAT_MTX_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412012 RAT_MTX_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412013 RAT_ANE_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412014 RAT_ANE_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412015 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412016 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412017 RAT_NORA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412018 RAT_NORA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412019 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412020 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412021 RAT_MTX_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412022 RAT_MTX_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412023 RAT_ANE_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412024 RAT_ANE_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412025 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412026 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412027 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412028 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412029 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412030 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412031 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412032 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412033 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412034 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412035 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412036 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap 5.563578357
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 21.8939592
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 21.98312362
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 6.350007724
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 34.84390651
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 30.69238734
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap 105.8143308
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 21.73025092
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 10.22464527
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 42.14856346
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 13.03096169
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 14.2447772
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 12.94485497
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 4.489789977

ID GSE752
Title Halothane/Isoflurane Repetitive Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5082 Control 1 67.9
GSM5084 Control 2 13.3
GSM5085 Control 3 31.1
GSM5086 Control 4 72.7
GSM5087 Control 5 10.4
GSM5090 Control 6 41.2
GSM5105 Control 7 13.5
GSM5106 Control 8 52.8
GSM5107 Control 9 22.7
GSM5108 Halothane 10 exposure-1 46.4
GSM5109 Halothane 10 exposures-2 42.0
GSM5110 Halothane 10 exposures-3 12.0
GSM5111 Halothane 5 exposures-1 35.9
GSM5112 Halothane 5 exposures-2 81.8
GSM5113 Halothane 5 exposures-3 10.5
GSM5114 Isoflurane 10 exposures-1 18.3
GSM5115 Isoflurane 10 exposures-2 46.6
GSM5116 Isoflurane 10 exposures-3 15.0
GSM5117 Isoflurane 5 exposures-1 35.4
GSM5118 Isoflurane 5 exposures-2 34.8
GSM5119 Isoflurane 5 exposures-3 14.1
GSM11379 Control 10 26.7
GSM11380 Control 11 15.6
GSM11381 Control 12 25.8

ID GSE8911
Title Skeletal muscle after fine needle stimulation
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM225891 Skeletal muscle sample from fine needle-stimulated hindlimb Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb 6.07613
GSM225892 Skeletal muscle sample from control hindlimb Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb 1.97825